Wallace RE - Search Results

1

Modulation of the immune response to tumors by a novel synthetic compound, N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763).

Wang BS, Ruszala-Mallon V, Wallace RE, Citarella RV, Lin YI, Durr FE. Wang BS, et al. Among authors: wallace re. Cancer Immunol Immunother. 1986;22(1):8-14. doi: 10.1007/BF00205710. Cancer Immunol Immunother. 1986. PMID: 2939949 Free PMC article.

2

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

Wallace RE, Murdock KC, Angier RB, Durr FE. Wallace RE, et al. Cancer Res. 1979 May;39(5):1570-4. Cancer Res. 1979. PMID: 427798

3

Induction of alloreactive immunosuppression by 1,4-bis [( 2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468).

Wang BS, Lumanglas AL, Ruszala-Mallon VM, Wallace RE, Durr FE. Wang BS, et al. Among authors: wallace re. Int J Immunopharmacol. 1984;6(5):475-82. doi: 10.1016/0192-0561(84)90086-9. Int J Immunopharmacol. 1984. PMID: 6334042

4

Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.

Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M. Citarella RV, et al. Among authors: wallace re. Cancer Res. 1982 Feb;42(2):440-4. Cancer Res. 1982. PMID: 7055799

5

Molecular and biochemical pharmacology of mitoxantrone.

Durr FE, Wallace RE, Citarella RV. Durr FE, et al. Among authors: wallace re. Cancer Treat Rev. 1983 Dec;10 Suppl B:3-11. doi: 10.1016/0305-7372(83)90016-6. Cancer Treat Rev. 1983. PMID: 6362876 Review.

6

Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.

Hinman LM, Hamann PR, Wallace R, Menendez AT, Durr FE, Upeslacis J. Hinman LM, et al. Cancer Res. 1993 Jul 15;53(14):3336-42. Cancer Res. 1993. PMID: 8324745

7

Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.

Murdock KC, Child RG, Fabio PF, Angier RB, Wallace RE, Durr FE, Citarella RV. Murdock KC, et al. Among authors: wallace re. J Med Chem. 1979 Sep;22(9):1024-30. doi: 10.1021/jm00195a002. J Med Chem. 1979. PMID: 490545

8

Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic mice.

Wallace RE, Lindh D, Durr FE. Wallace RE, et al. Cancer Chemother Pharmacol. 1989;25(2):117-23. doi: 10.1007/BF00692351. Cancer Chemother Pharmacol. 1989. PMID: 2480854

9

A new family of water-soluble, third generation antitumor platinum complexes.

Bitha P, Carvajal SG, Citarella RV, Delos Santos EF, Durr FE, Hlavka JJ, Lang SA Jr, Lindsay HL, Thomas JP, Wallace RE, et al. Bitha P, et al. Among authors: wallace re. J Med Chem. 1989 Sep;32(9):2063-7. doi: 10.1021/jm00129a008. J Med Chem. 1989. PMID: 2671371

10

Development of resistance and characteristics of a human colon carcinoma subline resistant to mitoxantrone in vitro.

Wallace RE, Lindh D, Durr FE. Wallace RE, et al. Cancer Invest. 1987;5(5):417-28. doi: 10.3109/07357908709032899. Cancer Invest. 1987. PMID: 3427507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters